Global Minimally Invasive Treatment Of Lung Cancer Market Trends 2025–2029: Regional Outlook and Sizing Analysis
Uncover key drivers, emerging technologies, and competitive movements shaping the minimally invasive treatment of lung cancer market from 2025–2034 with trusted insights from The Business Research Company
What Is The Projected Valuation Of The Minimally Invasive Treatment Of Lung Cancer Market In The Coming Years?
The minimally invasive treatment of lung cancer market size has demonstrated robust growth in recent years. It is anticipated to expand from $3.06 billion in 2024 to $3.35 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.7%. This historical growth can be attributed to several factors including the rising prevalence of lung cancer, increasing awareness regarding minimally invasive procedures, an expanding geriatric population, the adoption of early diagnosis methods, and the ongoing expansion of healthcare infrastructure.
The market for minimally invasive lung cancer treatment is anticipated to experience substantial expansion over the coming years. Projections indicate its value will reach $4.78 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period is fueled by several factors, including a growing preference for outpatient procedures, increased capital allocation towards specialized lung cancer facilities, wider access to minimally invasive treatment alternatives, governmental efforts to advance healthcare, and an emphasis on minimizing complications after surgery. Key trends shaping the market in this period encompass technological progress in surgical tools, new developments in patient surveillance systems, the evolution of precision therapy methods, ongoing research and development into less invasive interventions, and the incorporation of artificial intelligence for planning treatments.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27349&type=smp
Which Growth Drivers Are Shaping The Minimally Invasive Treatment Of Lung Cancer Market Outlook?
The rising occurrence of lung cancer is projected to drive the expansion of the minimally invasive treatment of lung cancer market in the coming years. This malignancy initiates in the lungs and is defined by the unchecked proliferation of cells. A significant factor contributing to the rise in lung cancer cases is the greater incidence of tobacco smoking, which fosters uncontrolled cellular growth and tumor development. Minimally invasive approaches benefit individuals with lung cancer by precisely targeting, eliminating, or ablating tumors via minor incisions or probes guided by imaging. This results in quicker recovery, less harm to healthy lung tissue, reduced complication risks, and an earlier return to regular life for patients. As an illustration, data from June 2025, provided by the Centers for Disease Control and Prevention, a US-based government agency, indicates that in 2022, the United States saw 218,893 new lung cancer diagnoses and 131,584 fatalities due to the disease. Consequently, the growing incidence of lung cancer is propelling the expansion of the minimally invasive treatment of lung cancer market.
What Is The Segment Breakdown Of The Minimally Invasive Treatment Of Lung Cancer Market?
The minimally invasive treatment of lung cancer market covered in this report is segmented
1) By Type: Lung Tumor Ablation, Lung Tumor Embolization
2) By Stage: Stage I, Stage II, Stage III, Stage IV
3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years
4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions
Subsegments:
1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation
2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization
How Are Global Trends Impacting The Development Of The Minimally Invasive Treatment Of Lung Cancer Market?
Major companies operating in the minimally invasive treatment of the lung cancer market are concentrating on developing advanced systems, such as fluoroscopic navigation platforms, to improve accuracy and enable targeted, localized lung treatment. Fluoroscopic navigation platforms function as medical imaging systems that integrate real-time fluoroscopy with navigation technology to precisely guide instruments to specific lung areas, facilitating minimally invasive biopsy and treatment of hard-to-reach lesions while also reducing complications. For instance, in July 2022, Medtronic plc, an Ireland-based medical technology company, announced the world’s first endoluminal lung ablation procedure utilizing the ILLUMISITE. This minimally invasive procedure, performed by physicians in Hong Kong, employed the ILLUMISITE platform to accurately navigate through a patient’s lungs using a customized virtual pathway based on their CT scan. The platform’s navigation catheter aided in guiding the bronchoscope to the lung lesion, where a specialized ablation catheter subsequently delivered targeted treatment. This innovation marks a significant milestone in lung mass diagnosis and treatment, by combining precise navigation with localized ablation technology.
Who Are The Major Stakeholders Operating In The Minimally Invasive Treatment Of Lung Cancer Market?
Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Weill Cornell Medicine, Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Biodesix Inc., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH.
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Minimally Invasive Treatment Of Lung Cancer Market?
North America was the largest region in the minimally invasive treatment of lung cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27349&type=smp
Browse Through More Reports Similar to the Global Minimally Invasive Treatment Of Lung Cancer Market 2025, By The Business Research Company
Credit Bureaus Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/credit-bureaus-global-market-report
Credit Card Issuance Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/credit-card-issuance-services-global-market-report
Personal Goods Repair And Maintenance Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
